GenBio AI
PrivateLast Round
Series A
Jun 24, 2026
Company Overview
GenBio AI is a biotechnology company that develops AI-driven multiscale foundation models to simulate, predict, and program biological systems for drug discovery and biomedical research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI, Synthetic Data
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenBio AI Comparables
Compare GenBio AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noetik | 86% | |
| CellType | 85% | |
| EvolutionaryScale | 83% | |
GenBio AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 24, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2025
Grew 30% QoQ, from 33 to 43 employees.
- Jul 18, 2025
Grew 38% QoQ, from 29 to 40 employees.
GenBio AI Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GenBio AI's valuation, stock price, and market status.